Yousif Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
11,090
-739
-6% -$162K 0.03% 551
2026
Q1
$2.24M Sell
11,829
-984
-8% -$172K 0.03% 609
2025
Q4
$2.15M Buy
12,813
+218
+2% +$33.4K 0.02% 668
2025
Q3
$1.66M Buy
12,595
+232
+2% +$27.8K 0.02% 822
2025
Q2
$1.31M Sell
12,363
-281
-2% -$30.5K 0.01% 977
2025
Q1
$1.57M Sell
12,644
-342
-3% -$44.6K 0.02% 857
2024
Q4
$1.6M Sell
12,986
-852
-6% -$100K 0.02% 883
2024
Q3
$1.54M Sell
13,838
-3,112
-18% -$341K 0.02% 916
2024
Q2
$1.81M Sell
16,950
-9,388
-36% -$1.03M 0.02% 813
2024
Q1
$3.17M Sell
26,338
-689
-3% -$84.4K 0.04% 555
2023
Q4
$3.32M Sell
27,027
-374
-1% -$46.7K 0.04% 523
2023
Q3
$3.55M Sell
27,401
-1,935
-7% -$258K 0.05% 434
2023
Q2
$3.64M Sell
29,336
-758
-3% -$102K 0.04% 444
2023
Q1
$4.4M Sell
30,094
-2,103
-7% -$311K 0.06% 354
2022
Q4
$5.13M Buy
32,197
+305
+1% +$44.7K 0.07% 295
2022
Q3
$4.25M Sell
31,892
-2,964
-9% -$451K 0.06% 331
2022
Q2
$5.44M Buy
34,856
+57
+0.2% +$8.78K 0.07% 269
2022
Q1
$5.42M Buy
34,799
+558
+2% +$81K 0.06% 324
2021
Q4
$4.36M Buy
+34,241
New +$4.5M 0.05% 456

Other funds holding JAZZ

Yousif Capital Management's JAZZ Position: Q2 2026 in Review

Yousif Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.2% in Q2 2026, selling an estimated $162K and leaving 11,090 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #551.

Yousif Capital Management first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.44M in Q2 2022. 78 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Yousif Capital Management held 11,090 shares of Jazz Pharmaceuticals worth $2.67M as of Q2 2026.
  • Yousif Capital Management sold 739 Jazz Pharmaceuticals shares in Q2 2026, an estimated $162K.
  • Jazz Pharmaceuticals made up 0.03% of Yousif Capital Management's portfolio in Q2 2026, its #551 holding.
  • Yousif Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Jazz Pharmaceuticals position peaked at $5.44M in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.